Skip to main content

Table 1 Clinico-pathological association of PTEN deletion

From: Partial PTEN deletion is linked to poor prognosis in breast cancer

   

PTEN FISH

 
  

Analyzable (n)

normal

deletion

P value

All cancers

 

1239

81 %

19 %

 

Histology

No special type

917

81 %

19 %

-

 

Lobular carcinoma

123

91 %

9 %

0.005*

 

Cribriform carcinoma

43

88 %

12 %

0.32

 

Medullary carcinoma

39

54 %

46 %

0.0001

 

Tubular carcinoma

28

96 %

4 %

0.04

 

Papillary carcinoma

17

65 %

35 %

0.11

 

Mucinous carcinoma

29

97 %

3 %

0.03

 

Other rare typesa

43

58 %

42 %

0.007

pT stage

pT1

411

87 %

13 %

0.005

 

pT2

613

78 %

22 %

 

pT3

61

77 %

23 %

 

pT4

146

79 %

21 %

BRE grade

Grade 1

308

93 %

7 %

<0.0001

 

Grade 2

472

87 %

13 %

 

Grade 3

457

68 %

32 %

Nodal stage

pN0

524

82 %

18 %

0.18

 

pN1

446

79 %

21 %

 

pN2

64

72 %

28 %

ER status

Negative

296

57 %

43 %

<0.0001

 

Positive

906

89 %

11 %

PR status

Negative

744

76 %

24 %

<0.0001

 

Positive

408

89 %

11 %

  1. Abbreviations: pT Pathological tumor, BRE Breast cancer histologic, ER Estrogen receptor, PR Progesterone receptor, FISH Fluorescence in-situ hybridization
  2. a: Including adenoid-cystic carcinoma, apocrine carcinoma, atypical medullary carcinoma, carcinosarcoma, clear cell carcinoma, histiocytic carcinoma, lipid rich carcinoma, lipid rich or histiocytic carcinoma, metaplastic carcinoma, neuroendocrine carcinoma, signet ring carcinoma, and small cell carcinoma
  3. *: Versus cancers of no special type